Results 171 to 180 of about 257,683 (336)

Diagnosis and management of gestational trophoblastic disease: 2025 update

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Gestational trophoblastic disease (GTD) arises from abnormal placenta and comprises a spectrum of premalignant to malignant disorders. Changes in the epidemiology of GTD have been noted in various countries. In addition to histology, molecular genetic studies can help in the diagnostic pathway.
Hextan Y. S. Ngan   +7 more
wiley   +1 more source

Influence of Puncture Devices on the Accuracy of Cyclophosphamide Dosing for Chemotherapy Administration. [PDF]

open access: yesPharmaceuticals (Basel)
Carvalho S   +4 more
europepmc   +1 more source

Prolongation of skin homografts in rabbits, using cyclophosphamide

open access: bronze, 1964
Jerry Jones   +3 more
openalex   +1 more source

Cancer and fertility management: FIGO best practice advice

open access: yesInternational Journal of Gynecology &Obstetrics, EarlyView.
Abstract Cancer diagnoses in patients of reproductive age require balancing urgent oncological treatment with the need to preserve fertility. This FIGO Best Practice Advice outlines key considerations for fertility management in this population given the rising cancer incidence among young women and the reproductive risks posed by cancer treatments ...
Nikhil Purandare   +28 more
wiley   +1 more source

Assessing the ovarian reserve in girls who survived childhood leukemia using anti-Mullerian hormone. [PDF]

open access: yesAnn Pediatr Endocrinol Metab
Jingrukwong L   +3 more
europepmc   +1 more source

An analysis of a multiple‐drug program in the treatment of patients with advanced breast cancer utilizing 5‐fluorouracil, cyclophosphamide, and prednisone with or without vincristine [PDF]

open access: bronze, 1975
David L. Ahmann   +7 more
openalex   +1 more source

Cyclophosphamide: An Overview

open access: yesClinical Dermatology Review
Cyclophosphamide (CPE) is an alkylating agent that has shown to have a wide range of applications in dermatology. Although not a first-line drug for any of the dermatological disorders, it has been found to be useful as a second-line drug in unresponsive cases. A major drawback of CPE is its toxicity profile.
openaire   +2 more sources

Late‐Onset Bone Metastasis 46 Years After Initial Surgery for Pheochromocytoma: A Case Report

open access: yesIJU Case Reports, EarlyView.
ABSTRACT Introduction Pheochromocytoma is a rare catecholamine‐producing tumor with metastatic potential. Recurrence after more than 40 years is exceptionally rare. Case Presentation During evaluation for ischemic colitis, a 71‐year‐old woman was found to have multiple bone metastases, possibly linked to catecholamine excess.
Fumio Ishizaki   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy